This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  86R11747 JCG-F
 
  By: Kacal H.B. No. 2425
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the authority of physicians to delegate to certain
  pharmacists the implementation and modification of a patient's drug
  therapy.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 157.101, Occupations Code, is amended by
  amending Subsection (b-1) and adding Subsection (g) to read as
  follows:
         (b-1)  A delegation under Subsection (b) may include the
  implementation or modification of a patient's drug therapy under a
  protocol, including the authority to sign a prescription drug order
  for dangerous drugs, if:
               (1)  the delegation follows a diagnosis, initial
  patient assessment, and drug therapy order by the physician;
               (2)  the pharmacist practices in a federally qualified
  health center, a hospital, a hospital-based clinic, or an academic
  health care institution;
               (3)  the federally qualified health center, hospital,
  hospital-based clinic, or academic health care institution in which
  the pharmacist practices has bylaws and a medical staff policy that
  permit a physician to delegate to a pharmacist the management of a
  patient's drug therapy;
               (4)  the pharmacist provides the name, address, and
  telephone number of the pharmacist and of the delegating physician
  on each prescription signed by the pharmacist; and
               (5)  the pharmacist provides a copy of the protocol to
  the Texas State Board of Pharmacy.
         (g)  In this section, "federally qualified health center"
  has the meaning assigned by Section 531.02192, Government Code.
         SECTION 2.  This Act takes effect September 1, 2019.